SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-21-028625
Filing Date
2021-12-15
Accepted
2021-12-15 11:44:59
Documents
14
Period of Report
2021-12-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K bcda20211214_8k.htm   iXBRL 8-K 29286
2 EXHIBIT 99.1 ex_316684.htm EX-99.1 9178
  Complete submission text file 0001437749-21-028625.txt   191191

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA noticker-20211214.xsd EX-101.SCH 4092
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE noticker-20211214_def.xml EX-101.DEF 13479
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE noticker-20211214_lab.xml EX-101.LAB 17677
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE noticker-20211214_pre.xml EX-101.PRE 13450
7 EXTRACTED XBRL INSTANCE DOCUMENT bcda20211214_8k_htm.xml XML 4362
Mailing Address 125 SHOREWAY ROAD SUITE B SAN CARLOS CA 94070
Business Address 125 SHOREWAY ROAD SUITE B SAN CARLOS CA 94070 650-226-0123
BioCardia, Inc. (Filer) CIK: 0000925741 (see all company filings)

IRS No.: 232753988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38999 | Film No.: 211493540
SIC: 2836 Biological Products, (No Diagnostic Substances)